BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25191323)

  • 21. DeltaguaBA attenuated Shigella flexneri 2a strain CVD 1204 as a Shigella vaccine and as a live mucosal delivery system for fragment C of tetanus toxin.
    Anderson RJ; Pasetti MF; Sztein MB; Levine MM; Noriega FR
    Vaccine; 2000 Apr; 18(21):2193-202. PubMed ID: 10717338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral immunization with a Salmonella enterica serovar typhi vaccine induces specific circulating mucosa-homing CD4(+) and CD8(+) T cells in humans.
    Lundin BS; Johansson C; Svennerholm AM
    Infect Immun; 2002 Oct; 70(10):5622-7. PubMed ID: 12228290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma cells are not restricted to the CD27+ phenotype: characterization of CD27-CD43+ antibody-secreting cells.
    Covens K; Verbinnen B; de Jong BG; Moens L; Wuyts G; Verheyen G; Nys K; Cremer J; Smulders S; Schrijvers R; Weinhäusel A; Vermeire S; Verschueren P; Langhe E; van Dongen JJM; van Zelm MC; Bossuyt X
    Front Immunol; 2023; 14():1165936. PubMed ID: 37492569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Robust mucosal-homing antibody-secreting B cell responses induced by intramuscular administration of adjuvanted bivalent human norovirus-like particle vaccine.
    Sundararajan A; Sangster MY; Frey S; Atmar RL; Chen WH; Ferreira J; Bargatze R; Mendelman PM; Treanor JJ; Topham DJ
    Vaccine; 2015 Jan; 33(4):568-76. PubMed ID: 25444793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Further characterization of delta aroA delta virG Shigella flexneri 2a strain CVD 1203 as a mucosal Shigella vaccine and as a live-vector vaccine for delivering antigens of enterotoxigenic Escherichia coli.
    Noriega FR; Losonsky G; Wang JY; Formal SB; Levine MM
    Infect Immun; 1996 Jan; 64(1):23-7. PubMed ID: 8557344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered Distribution of Peripheral Blood Maturation-Associated B-Cell Subsets in Chronic Alcoholism.
    Almeida J; Polvorosa MA; Gonzalez-Quintela A; Madruga I; Marcos M; Pérez-Nieto MA; Hernandez-Cerceño ML; Orfao A; Laso FJ
    Alcohol Clin Exp Res; 2015 Aug; 39(8):1476-84. PubMed ID: 26146763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG.
    Kotloff KL; Noriega F; Losonsky GA; Sztein MB; Wasserman SS; Nataro JP; Levine MM
    Infect Immun; 1996 Nov; 64(11):4542-8. PubMed ID: 8890204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral priming with Salmonella Typhi vaccine strain CVD 909 followed by parenteral boost with the S. Typhi Vi capsular polysaccharide vaccine induces CD27+IgD-S. Typhi-specific IgA and IgG B memory cells in humans.
    Wahid R; Pasetti MF; Maciel M; Simon JK; Tacket CO; Levine MM; Sztein MB
    Clin Immunol; 2011 Feb; 138(2):187-200. PubMed ID: 21146460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and immunogenicity study of the auxotrophic Shigella flexneri 2a vaccine SFL1070 with a deleted aroD gene in adult Swedish volunteers.
    Kärnell A; Li A; Zhao CR; Karlsson K; Nguyen BM; Lindberg AA
    Vaccine; 1995 Jan; 13(1):88-99. PubMed ID: 7762285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A bivalent vaccine confers immunogenicity and protection against
    Medeiros PHQS; Bolick DT; Ledwaba SE; Kolling GL; Costa DVS; Oriá RB; Lima AÂM; Barry EM; Guerrant RL
    NPJ Vaccines; 2020; 5(1):30. PubMed ID: 32257392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety, immunogenicity, and efficacy in monkeys and humans of invasive Escherichia coli K-12 hybrid vaccine candidates expressing Shigella flexneri 2a somatic antigen.
    Kotloff KL; Herrington DA; Hale TL; Newland JW; Van De Verg L; Cogan JP; Snoy PJ; Sadoff JC; Formal SB; Levine MM
    Infect Immun; 1992 Jun; 60(6):2218-24. PubMed ID: 1587589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA-DRhigh/CD27high plasmablasts indicate active disease in patients with systemic lupus erythematosus.
    Jacobi AM; Mei H; Hoyer BF; Mumtaz IM; Thiele K; Radbruch A; Burmester GR; Hiepe F; Dörner T
    Ann Rheum Dis; 2010 Jan; 69(1):305-8. PubMed ID: 19196727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Shigella antigen-specific B memory cells are associated with decreased disease severity in subjects challenged with wild-type Shigella flexneri 2a.
    Wahid R; Simon JK; Picking WL; Kotloff KL; Levine MM; Sztein MB
    Clin Immunol; 2013 Jul; 148(1):35-43. PubMed ID: 23649043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and immunogenicity of the live oral auxotrophic Shigella flexneri SFL124 in adult Vietnamese volunteers.
    Li A; Kärnell A; Huan PT; Cam PD; Minh NB; Trâm LN; Quy NP; Trach DD; Karlsson K; Lindberg G
    Vaccine; 1993; 11(2):180-9. PubMed ID: 8438616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic Reprogramming Commits Differentiation of Human CD27
    Torigoe M; Iwata S; Nakayamada S; Sakata K; Zhang M; Hajime M; Miyazaki Y; Narisawa M; Ishii K; Shibata H; Tanaka Y
    J Immunol; 2017 Jul; 199(2):425-434. PubMed ID: 28626065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased frequencies of circulating follicular helper T cell counterparts and plasmablasts in ankylosing spondylitis patients Naïve for TNF blockers.
    Bautista-Caro MB; Arroyo-Villa I; Castillo-Gallego C; de Miguel E; Peiteado D; Plasencia-Rodríguez C; Villalba A; Sánchez-Mateos P; Puig-Kröger A; Martín-Mola E; Miranda-Carús ME
    PLoS One; 2014; 9(9):e107086. PubMed ID: 25203742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AroD deletion attenuates Shigella flexneri strain 2457T and makes it a safe and efficacious oral vaccine in monkeys.
    Kärnell A; Cam PD; Verma N; Lindberg AA
    Vaccine; 1993; 11(8):830-6. PubMed ID: 8356844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotypic Characterization of Chinese Rhesus Macaque Plasmablasts for Cloning Antigen-Specific Monoclonal Antibodies.
    Zhang F; Wang L; Niu X; Li J; Luo J; Feng Y; Yang Y; He P; Fan W; Liang R; Zheng Z; Pan W; Li C; Tan YJ; Yu H; Chen L; Li P
    Front Immunol; 2019; 10():2426. PubMed ID: 31681312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and immunogenicity of a Shigella flexneri 2a Invaplex 50 intranasal vaccine in adult volunteers.
    Tribble D; Kaminski R; Cantrell J; Nelson M; Porter C; Baqar S; Williams C; Arora R; Saunders J; Ananthakrishnan M; Sanders J; Zaucha G; Turbyfill R; Oaks E
    Vaccine; 2010 Aug; 28(37):6076-85. PubMed ID: 20619378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Homing commitment of lymphocytes activated in the human gastric and intestinal mucosa.
    Quiding-Järbrink M; Ahlstedt I; Lindholm C; Johansson EL; Lönroth H
    Gut; 2001 Oct; 49(4):519-25. PubMed ID: 11559649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.